Condition: Coronary Artery Disease · Sponsor: Biotronik AG
The registry follows the ESC/EACTS guideline and further investigates the clinical performance and short-term safety of RMS (Resorbable Magnesium Scaffolds) in a real world setting within the scope of its intended use without further (medical related) exclusion criteria according to their respective instructions for use (IFU).
This description comes directly from the study's public registry record.
Marina Gattiglio, Dr. · +41754295843 · marina.gattiglio@teleflex.com
Always discuss trial participation with your own doctor first.
| Cairns Hospital | Cairns, Australia | Completed |
| Heart Center Segeberger Kliniken | Bad Segeberg, Germany | Recruiting |
| Krankenhaus Buchholz | Buchholz, Germany | Completed |
| Klinikum Westfalen, Knappschaft KH | Dortmund, Germany | Completed |
| Klinikum Herford | Herford, Germany | Completed |
| Herz-und Gefäßzentrum Oberallgäu-Kempten | Kempten, Germany | Completed |
| Centro Cardiologico Monzino | Milan, Lombardy, Italy | Recruiting |
| Daugavpils Regional Hospital | Daugavpils, Latvia | Completed |
| 1 Wojskowy Szpital Kliniczny z Poliklinika SPZOZ w Lublinie | Lublin, Poland | Recruiting |
| SUSCCH Banska Bystrica | Banská Bystrica, Slovakia | Completed |
| Lindenhofspital | Bern, Switzerland | Recruiting |
| Centre Hospitalier Universitaire Vaudois | Lausanne, Switzerland | Recruiting |
+ 1 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04679740